Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin

Dora Beke; Martin Pecherstorfer

doi:10.1007/s10354-008-0630-z

Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin

Translated title of the contribution: Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care

Dora Beke
, Martin Pecherstorfer

Research output: Journal article (peer-reviewed) › Journal article

Abstract

Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.

Translated title of the contribution	Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care
Original language	German
Pages (from-to)	702-706
Number of pages	5
Journal	Wiener Medizinische Wochenschrift
Volume	158
Issue number	23-24
DOIs	https://doi.org/10.1007/s10354-008-0630-z
Publication status	Published - 2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/s10354-008-0630-z

Cite this

@article{da527626c2f24a18b659dc96deffee9d,

title = "Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin",

abstract = "Bone metastases are one of the most common complications of cancer. Up to 70\% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.",

keywords = "Bone Density Conservation Agents/adverse effects, Bone Neoplasms/secondary, Breast Neoplasms/therapy, Carcinoma, Ductal/secondary, Combined Modality Therapy, Diphosphonates/adverse effects, Disease Progression, Female, Humans, Image Processing, Computer-Assisted, Imaging, Three-Dimensional, Mandibular Diseases/chemically induced, Maxillary Diseases/chemically induced, Middle Aged, Neoplasm Recurrence, Local/therapy, Osteonecrosis/chemically induced, Tomography, X-Ray Computed, Osteonecrosis of the jaw, Bisphosphonates, Bone metastasis",

author = "Dora Beke and Martin Pecherstorfer",

year = "2008",

doi = "10.1007/s10354-008-0630-z",

language = "Deutsch",

volume = "158",

pages = "702--706",

journal = "Wiener Medizinische Wochenschrift",

issn = "0043-5341",

publisher = "Springer",

number = "23-24",

}

TY - JOUR

T1 - Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin

AU - Beke, Dora

AU - Pecherstorfer, Martin

PY - 2008

Y1 - 2008

N2 - Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.

AB - Bone metastases are one of the most common complications of cancer. Up to 70% of patients with advanced breast cancer metastasize to the bone. The standard long-term treatment of bone metastases is bisphosphonates. This effective therapy, however, is able to cause serious side effects. Osteonecrosis of the jaw (ONJ) is a recently detected adverse outcome associated in rare cases with bisphosphonate therapy.

KW - Bone Density Conservation Agents/adverse effects

KW - Bone Neoplasms/secondary

KW - Breast Neoplasms/therapy

KW - Carcinoma, Ductal/secondary

KW - Combined Modality Therapy

KW - Diphosphonates/adverse effects

KW - Disease Progression

KW - Female

KW - Humans

KW - Image Processing, Computer-Assisted

KW - Imaging, Three-Dimensional

KW - Mandibular Diseases/chemically induced

KW - Maxillary Diseases/chemically induced

KW - Middle Aged

KW - Neoplasm Recurrence, Local/therapy

KW - Osteonecrosis/chemically induced

KW - Tomography, X-Ray Computed

KW - Osteonecrosis of the jaw

KW - Bisphosphonates

KW - Bone metastasis

UR - https://www.scopus.com/pages/publications/64149094346

U2 - 10.1007/s10354-008-0630-z

DO - 10.1007/s10354-008-0630-z

M3 - Artikel in Fachzeitschrift

C2 - 19165450

SN - 0043-5341

VL - 158

SP - 702

EP - 706

JO - Wiener Medizinische Wochenschrift

JF - Wiener Medizinische Wochenschrift

IS - 23-24

ER -

Bisphosphonate und Kiefernekrose--eine zunehmende Herausforderung in der Palliativmedizin

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this